Lacey R. McNally, PhD
Metastasis is responsible for the large majority of cancer-related deaths in the US. My research is focused in three areas including experimental therapy for metastasis, identification of biomarkers to indicate chemoresistance, and racial disparity in cancer treatment. The overall goal is to develop an effective therapeutic strategy for treatment of metastasis, specifically in pancreatic and ovarian cancer patients, as well as to identify mechanisms of chemoresistance. A new area of research for my laboratory is to identify biomarkers and signaling pathways in pancreatic cancer which are altered based on race, which would indicate alternative therapies and give patients more personalized treatment options.